We found that the SIRT2 expression level was related to different clinical covariates, including the history of neoadjuvant therapy, person neoplasm cancer status, primary therapy outcome success, ethnicity, and some other clinical characteristics in LUAD and LUSC cohorts using MEXPRESS database (Figure 2 upper). The gene discussed is SIRT2; the disease is cancer.